Oncogenic role of early growth response-1 in liver cancer through the regulation of the microRNA-675/sestrin 3 and the Wnt/β-catenin signaling pathway

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Karadag Soylu N. Update on hepatocellular carcinoma: a brief review from pathologist standpoint. J Gastrointest Cancer. 2020;51(4):1176–1186.
   PubMed Web of Science ®Google Scholar
• Liu J, Sun G, Pan S, et al. The Cancer Genome Atlas (TCGA) based m6 A methylation-related genes predict prognosis in hepatocellular carcinoma. Bioengineered. 2020;11(1):759–768.
   PubMed Web of Science ®Google Scholar
• Pinter M, Peck-Radosavljevic M. Review article: systemic treatment of hepatocellular carcinoma. Aliment Pharmacol Ther. 2018;48(6):598–609.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu X, Ge G, et al. miR498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Oncol Rep. 2019;41:1638–1648.
   PubMed Web of Science ®Google Scholar
• Li TT, Liu MR, Pei DS. Friend or foe, the role of EGR-1 in cancer. Med Oncol. 2019;37(1):7.
   PubMed Web of Science ®Google Scholar
• Gitenay D, Baron VT. Is EGR1 a potential target for prostate cancer therapy? Future Oncol. 2009;5(7):993–1003.
   PubMed Web of Science ®Google Scholar
• Li L, Ameri AH, Wang S, et al. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene. 2019;38(35):6241–6255.
   PubMed Web of Science ®Google Scholar
• Kim J, Jung E, Choi J, et al. Leptin is a direct transcriptional target of EGR1 in human breast cancer cells. Mol Biol Rep. 2019;46(1):6241–6255.
   Web of Science ®Google Scholar
• Yang Y, Wu F, Zhang J, et al. EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer. J Cell Mol Med. 2019;23(11):7372–7381.
   PubMed Web of Science ®Google Scholar
• Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126–132.
   PubMed Web of Science ®Google Scholar
• Gabory A, Ripoche MA, Yoshimizu T, et al. The H19 gene: regulation and function of a non-coding RNA. Cytogenet Genome Res. 2006;113(1–4):188–193.
   PubMed Web of Science ®Google Scholar
• Alipoor B, Parvar SN, Sabati Z, et al. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance. Mol Biol Rep. 2020;47(8):6357–6374.
   PubMed Web of Science ®Google Scholar
• Ge L, Zhang X, Hu S, et al. H19 suppresses the growth of hepatoblastoma cells by promoting their apoptosis via the signaling pathways of miR-675/FADD and miR-138/PTK2. J Cell Biochem. 2019;120(4):5218–5231.
   PubMed Web of Science ®Google Scholar
• Ho A, Cho CS, Namkoong S, et al. Biochemical basis of sestrin physiological activities. Trends Biochem Sci. 2016;41(7):621–632.
   PubMed Web of Science ®Google Scholar
• Huang M, Kim HG, Zhong X, et al. Sestrin 3 protects against diet-induced nonalcoholic steatohepatitis in mice through suppression of transforming growth factor β signal transduction. Hepatology. 2020;71(1):76–92.
   PubMed Web of Science ®Google Scholar
• Liu Y, Kim HG, Dong E, et al. Sesn3 deficiency promotes carcinogen-induced hepatocellular carcinoma via regulation of the hedgehog pathway. Biochim Biophys Acta Mol Basis Dis. 2019;1865(10):2685–2693.
   PubMed Web of Science ®Google Scholar
• Shan QL, Chen NN, Meng GZ, et al. <p>Overexpression of lncRNA MT1JP mediates apoptosis and migration of hepatocellular carcinoma cells by regulating miR-24-3p. Cancer Manag Res. 2020;12:4715–4724.
   PubMed Web of Science ®Google Scholar
• Liu L, Lu L, Zheng A, et al. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma. Oncotarget. 2017;8(8):13666–13677.
   PubMedGoogle Scholar
• Liu D, Chen C, Cui M, et al. miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2. Cancer Med. 2021;10(10):3358–3372.
   PubMed Web of Science ®Google Scholar
• Yao L, Zhou Y, Sui Z, et al. HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells. EBioMedicine. 2019;48:117–129.
   PubMed Web of Science ®Google Scholar
• Li Z, Lu J, Zeng G, et al. MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4). Cell Death Dis. 2019;10(11):789.
   PubMedGoogle Scholar
• Bi JG, Zheng JF, Li Q, et al. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. Int J Biochem Cell Biol. 2019;106:107–116.
   PubMed Web of Science ®Google Scholar
• Ho BC, Yu SL, Chen JJ, et al. Enterovirus-Induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe. 2011;9(1):58–69.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Barrett T, Edgar R. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol. 2006;411:352–369.
   PubMed Web of Science ®Google Scholar
• Abdulkadir SA, Qu Z, Garabedian E, et al. Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med. 2001;7(1):3358–3367.
   PubMed Web of Science ®Google Scholar
• Chen DG, Zhu B, Lv SQ, et al. Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter. J Exp Clin Cancer Res. 2017;36(1):186.
   PubMedGoogle Scholar
• Zhang Q, Song G, Yao L, et al. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J Exp Clin Cancer Res. 2018;37(1):14.
   PubMedGoogle Scholar
• De Martino M, Palma G, Azzariti A, et al. The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 upregulation by activating Egr1 through a ceRNA Mechanism. Genes (Basel). 2017;8(11):330.
   Web of Science ®Google Scholar
• Li H, Li J, Jia S, et al. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer. Oncotarget. 2015;6(31):31958–31984.
   PubMedGoogle Scholar
• Liu L, Tian YC, Mao G, et al. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1. Cell Signal. 2019;62:109352.
   PubMed Web of Science ®Google Scholar
• Dai Y, Miao Y, Zhu Q, et al. Expression of long non-coding RNA H19 predicts distant metastasis in minimally invasive follicular thyroid carcinoma. Bioengineered. 2019; 10(1):383–389.„ (PMID: 31791180).
   Google Scholar
• Zhang H, Yu Y, Zhang K, et al. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis. Bioengineered. 2019;10(1):306–315.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou P, Li P, et al. Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1. Bioengineered. 2020;11(1):536–546.
   PubMed Web of Science ®Google Scholar
• Zhang T, Lei F, Jiang T, et al. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells. Curr Mol Pharmacol. 2019; 12(4):324–333.
   PubMed Web of Science ®Google Scholar
• Hernandez JM, Elahi A, Clark CW, et al. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma. Ann Surg Oncol. 2013;20(Suppl 1):S625–35.
   PubMedGoogle Scholar
• Li ZW, Zhang TY, Yue GJ, et al. Small nucleolar RNA host gene 22 (SNHG22) promotes the progression of esophageal squamous cell carcinoma by miR-429/SESN3 axis. Ann Transl Med. 2020;8(16):1007.
   PubMed Web of Science ®Google Scholar
• Yang G, Shen T, Yi X, et al. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer. J Cell Mol Med. 2018;22(4):31958–31984.
   Web of Science ®Google Scholar
• Vilchez V, Turcios L, Marti F, et al. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol. 2016;22(2):823–832.
   PubMed Web of Science ®Google Scholar